Model Informed Drug Development Archives

On-Demand Webinar

第 2 部分：Oligonucleotide therapeutic development: Pre-clinical and translational considerations

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

Certara2021 年 4 月 21 日

网络研讨会点播

第 1 部分：What are oligonucleotide therapeutics, and how do they work?

In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…

Certara2021 年 4 月 21 日

On-Demand Webinar

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…

Certara2021 年 4 月 1 日

Publication

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

The extent of cross-protection provided by currently licensed bivalent and quadrivalent HPV vaccines versus direct…

Certara2021 年 3 月 18 日

On-Demand Webinar

Sealing Pharma Commercialization Deals：为投资者创造最佳价值

It is crucial for biotech developers to engage in early commercial market assessment to generate…

Certara2021 年 3 月 5 日

Publication

BPS Article: 模型引导的药物再利用：新型病原体准备、反应和回顾的定量药理学方法

Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…

Certara2021 年 2 月 9 日

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

Certara2021 年 2 月 3 日

On-Demand Webinar

How drug developers can avoid these common mistakes to secure a deal

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

Certara2021 年 1 月 21 日

On-Demand Webinar

Making your biotech program investor-ready

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

Certara2021 年 1 月 21 日

On-Demand Webinar

新兴生物技术公司资产评估简介

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

Certara2021 年 1 月 21 日

模型引导的药物开发

第 2 部分：Oligonucleotide therapeutic development: Pre-clinical and translational considerations

第 1 部分：What are oligonucleotide therapeutics, and how do they work?

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Sealing Pharma Commercialization Deals：为投资者创造最佳价值

BPS Article: 模型引导的药物再利用：新型病原体准备、反应和回顾的定量药理学方法

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

How drug developers can avoid these common mistakes to secure a deal

Making your biotech program investor-ready

新兴生物技术公司资产评估简介

订阅时事通讯

快捷链接

解决方案

联系我们